Analgesic effect of Lidocaine-ketorolac versus lidocaine-dexmedetomidine for intravenous regional anesthesia
Phase 2
- Conditions
- Regional anesthesia.Local anaesthetics
- Registration Number
- IRCT2014090614056N3
- Lead Sponsor
- Arak University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
age between 20 to 50 years old; ASA I or II. Exclusion criteria: drug allergy history; history of cardiac disease; hypertension treated with methyl dopa and clonidine; bradycardia; pregnancy; hematologic disorders and coagulopathies; renal diseases; gastrointestinal bleeding; operation duration lesser than 40 and over 90 minutes; opiate or analgesic drugs history.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tourniquet pain. Timepoint: After injection then 15, 30 and 45 minute after injection. Method of measurement: VAS.
- Secondary Outcome Measures
Name Time Method Reduction of pain. Timepoint: Every 30 minutes until 2 hours after removing tourniquet. Method of measurement: VAS.;Vital signs. Timepoint: After removing tourniquet. Method of measurement: Common ways.;O2 saturation. Timepoint: After removing tourniquet. Method of measurement: Pulse oxymeter.